Best Emerging Pharma Company/start up

This award recognises an outstanding emerging pharmaceutical company or start-up that has demonstrated innovation, growth, and impact within the UK pharma industry. The winner will be a company that has shown exceptional promise through pioneering research, novel drug development, strategic partnerships, or technological advancements. This category celebrates businesses that are poised to shape the future of pharmaceuticals with their innovative approaches and commitment to improving patient outcomes. Entry is by a 5-page A4 PDF submission; the judges will be looking for a clear plan and evidence that it is delivering on core objectives, paying attention to the criteria listed below.

• Innovation & Scientific Breakthroughs: Evidence of groundbreaking research, novel drug development, or disruptive technologies that differentiate the company in the market.
• Business Growth & Market Potential: Demonstrated progress in business development, funding success, commercial strategy, and scalability within the UK and beyond.
• Regulatory & Compliance Excellence: Strong adherence to industry regulations, ethical standards, and best practices in clinical trials, manufacturing, and distribution.
• Impact on Patient Care & Public Health: Tangible contributions to patient outcomes, healthcare accessibility, or advancements in therapeutic areas with unmet medical needs.
• Strategic Partnerships & Industry Influence: Engagement in collaborations with academic institutions, healthcare providers, or other pharma/biotech companies to drive innovation and industry progress.
• Sustainability & Corporate Responsibility: Commitment to sustainable practices, ethical business operations, and corporate social responsibility within the pharma sector.